Latest News
Keep up to date with all our latest investments, service offerings and news items.
Click here to view our latest media kit
-
-
March 15, 2023
Almac Sciences successfully completes an outstanding Knowledge Transfer Partnership with QUB
-
February 21, 2023
Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories
-
January 26, 2023
Almac Group Opens Registration for Internationally Recognized Process Chemistry Forum in Belfast
-
December 14, 2022
Almac Group secures HPRA certification for biologics testing
-
December 6, 2022
Almac Group Completes First Stage of GMP API Facility Expansion
-
December 1, 2022
Almac’s Higher Level Apprentice success in WorldSkills UK National Competition
-
December 1, 2022
Odyssey Trust invests £3 million in state-of-the-art new center to offer Learning Innovation for Everyone
-
November 15, 2022
Almac Group Hosts Internationally Recognized Chemistry R&D Forum in Belfast
-
September 6, 2022
Almac Sciences and UCD strengthen collaboration with prestigious SFI grant
-
August 2, 2022
Almac Group Expands Laboratory Scale Jet Milling Capabilities for Formulation and Toxicology Studies
-
June 15, 2022
Rising talent receives prestigious £1.5M UKRI Future Leaders Fellowship
-
September 22, 2021
Almac Sciences and Queen’s University Belfast Collaboration Successfully Flows Through Mid-point
-
August 10, 2021
Almac Group and PILA PHARMA Ink Manufacturing Agreement
-
March 8, 2021
Almac Group Announces Four-Year PhD Scholarship at UCL
-
February 23, 2021
Almac Group Completes £5million Research & Development Center
-
January 26, 2021
Almac Group Further Expands Global Biologics Testing Solutions
-
January 12, 2021
Almac Group Awarded £Multimillion R&D Grant to Accelerate Enzyme Discovery Unique INSIGHT™ project builds on Almac’s existing enzyme expertise
-
December 10, 2020
Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery
-
November 17, 2020
Almac Group Works to enable efficient manufacturing of remdesivir in Response to COVID-19
-
October 14, 2020
Almac Sciences Achieves Thought Leadership Milestone
-
October 7, 2020
Almac Group Appoints Vice President of Small Molecule API
-
September 8, 2020
Arran Chemical Company Continues Unique Industry – Academia Collaboration with Athlone Institute of Technology
-
July 22, 2020
Almac Group “CATCH”es a SFI Industry Fellowship
-
November 1, 2019
Almac Group Hosts Internationally Recognized Chemistry Forum in Belfast
-
July 8, 2019
Arran Chemical Company forms Unique Industry – Academia Collaboration with Athlone Institute of Technology
-
February 25, 2019
Almac Group Engages with Science Exchange to Promote US Small Molecule Analytical Services
-
January 8, 2019
Almac Group Flows into Continuous Technology
-
January 2, 2019
Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing
-
October 1, 2018
Almac Group Launches Global Analytical Services Capability
-
July 27, 2018
Almac Group Launches GMP High Throughput Peptide Manufacturing Service
-
May 1, 2018
Almac Group Appoints David Taylor as Head of Manufacturing Operations
-
January 29, 2018
Almac Group Appoints Dr Stefan Mix as Head of Biocatalysis
-
January 24, 2018
Almac Group Launches Bespoke Elemental Impurities Laboratory
-
January 2, 2018
Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing
-
December 5, 2017
Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland
-
December 13, 2016
Almac Group Appoints Professor Tom Moody as VP of Technology Development and Commercialization
-
October 14, 2016
Almac Group Wins Prestigious Research and Development Award
-
May 23, 2016
Almac to partner with ZYMtronix to deploy its universal enzyme immobilization platform
-
January 25, 2016
NEW Fluorescence Lifetime Platform Unveiled at SLAS
-
November 3, 2015
Almac Acquires Arran Chemical Company and Expands Biocatalysis Services
-
July 10, 2015
Almac Group Appoints Dr. John Robson as VP Quality Operations
-
February 5, 2015
Almac Group Drives Biocatalysis Leadership with a Further $7M Investment
-
December 10, 2013
Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013
-
November 13, 2013
Almac’s Strengthened Facilities Accommodates Demand of Late Stage API Manufacture
-
October 22, 2013
Novozymes Biopharma announces collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies
-
October 7, 2013
Almac Launches New [14C]-labelled ADCs Service Offering
-
May 15, 2013
Almac secures new metagenomics and enzyme discovery program with UCL
-
February 20, 2013
Almac Receives FDA Inspection Approval
-
January 21, 2013
Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade
-
January 7, 2013
Almac and TTP Labtech form alliance in fluorescence lifetime technology
-
October 9, 2012
Almac Concludes Commercial API Manufacturing Facility Expansion Plans
-
October 8, 2012
Almac and DSM Sign Collaboration Agreement in Biocatalysis
-
September 17, 2012
Almac Launches New Histone Reagents Catalog and Custom Synthesis Service
-
June 11, 2012
Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products
-
February 13, 2012
selectAZyme™ grows into metabolite synthesis
-
January 23, 2012
Almac Celebrates MHRA Audit Successes
-
January 17, 2012
MGB Biopharma and Almac Collaborate on Contract Manufacturing Project
-
October 25, 2011
Almac’s rapidd continuing to accelerate early stage development 2 years on
-
October 24, 2011
Almac Invests in New Commercial API Manufacturing
-
May 4, 2011
Almac Introduces selectAZymeTM
-
March 28, 2011
BioFocus and Almac collaborate to offer fluorescent lifetime assays
-
November 23, 2010
Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com
-
October 7, 2010
Almac continues biocatalysis business growth with a further $4m R&D investment
-
April 29, 2010
Almac extends Site-specific PEGylation Technology to single domain antibodies
-
April 7, 2010
New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing
-
February 26, 2010
Almac Expands Radiolabeling Facilities to Include 14C API and IMP Supply
-
January 18, 2010
Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays
-
November 2, 2009
Almac Launches Unique Site-specific PEGylation Technology at BIO Europe
-
October 14, 2009
“rapidd” Accelerating Early Stage Development, Minimizing Cash Burn
-
October 13, 2009
Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec
-
July 21, 2009
MHRA Grants Almac IMP License for its Radiolabeling Service
-
April 23, 2009
Almac Launches Biocatalyst Kits
-
January 29, 2009
Almac Promotes Biocatalysis and Radiolabeling
-
December 5, 2007
Almac Sciences: a global supply chain approach
-
December 5, 2007
Almac Sciences: “First in man” approach to peptides
-
March 8, 2007
Almac Sciences Invest In Edinburgh Facility
-
February 14, 2007
SafeBridge® Certification for Almac Sciences’ cytotoxics plant
-
February 14, 2007
Almac Sciences and BioCatalytics Inc. to co-operate on key pharma products
-
February 14, 2007
CPST fill-and-finish agreement for Almac Sciences’ cytotoxics
-
October 10, 2006
Almac Sciences Scales Up for Peptides
-
February 16, 2006
CSS Radio Goes Live; Chiral Building Blocks Range Announced
-
November 29, 2005
CSS Focuses on Australian Market
-
November 25, 2005
CSS Launches Global Provision of Radiolabeling Services
-
March 4, 2005
CSS Albachem Secures a Share of £3.7 million R&D Program
-
December 21, 2004
Chiral Consortium
-
December 7, 2004
CSS Enters Chiral Market Through Collaborations with ChiralQuest and IEP
-
October 28, 2004
CSS Launches Unique Consortium at CPhI
-
May 10, 2004
CSS Acquires Controlling Interest in Peptide Company ALBACHEM
-
September 1, 2003
Senator GEORGE MITCHELL Officially Opens New CSS Facility